Fuller & Thaler Asset Management
BIVV

Fuller & Thaler Asset Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Fuller & Thaler Asset Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,800
Closed -$97K – 851
2017
Q4 		$97K Buy
+1,800
New +$98.5K ﹤0.01% 526

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Fuller & Thaler Asset Management's BIVV Position: Q1 2018 in Review

Fuller & Thaler Asset Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 1,800 shares — an estimated $97K sold.

Fuller & Thaler Asset Management first reported a position in BIVV in Q4 2017 and held it in 1 quarter. The position peaked at $97K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Fuller & Thaler Asset Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 1,800 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $97K.
  • Fuller & Thaler Asset Management first reported a position in Bioverativ Inc. Common Stock in Q4 2017 and held it in 1 quarter.
  • Fuller & Thaler Asset Management's Bioverativ Inc. Common Stock position peaked at $97K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Fuller & Thaler Asset Management's 13F filing for Q1 2018, filed 14 May 2018.